dismiss

Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

advertisement

 

Molecular Imaging Homepage

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Dennis Durmis MITA names chair of board of directors

Researchers find new PET tracer that better detects melanoma than 18F-FDG 18F-P3BZA could become the new gold standard

RadioMedix scores $2 million contract for Targeted Alpha-emitter therapy Treatment for neuroendocrine tumors

FDA clears United Imaging's total-body PET scanner Creating 3D images of entire human body in 15-30 seconds

FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients

Rob Beanlands ASNC names president for 2019

Rendering of IAMI
(Photo credit: Architecture49)

Canada to build medical isotope research and development center

por John R. Fischer , Staff Reporter
The Canadian government has pledged to invest in funding for the construction of an advanced medical isotope research and development center that will comprise certified infrastructure for isotope production.

Announced by Prime Minister Justin Trudeau at Canada’s particle accelerator center, TRIUMF, the public investment, along with contributions by project partners BC Cancer Foundation and the University of British Columbia, will provide a total of $31.8 million for the architectural setup of the Institute for Advanced Medical Isotopes (IAMI), designed to expand Canada’s position in the nuclear medicine market.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



“The IAMI facility will be a nexus for multidisciplinary expertise from research and industry and will contain both a state-of-the-art, high-capacity TR-24 cyclotron and modern radiopharmaceutical production laboratories,” Dr. Paul Schaffer, associate laboratory director of TRIUMF's Life Sciences Division, told HCB News. “Its location at TRIUMF will enable unfettered access to some of the unique isotopes that can only be produced using TRIUMF’s high-energy particle accelerator infrastructure, including isotopes such as actinium-225 (225Ac), that are seeing dramatically increasing global demand.”

The IAMI project is expected to total more than $50 million with the addition of equipment and philanthropic funding, leading to an integrated set of labs and a TR-24 medical cyclotron, one of the most technologically advanced commercial cyclotrons in the world, housed within the finished facility.

Included in its offerings are next-generation cancer therapies for improving Canadian health outcomes and opening up access to radionuclide therapy markets, accelerated global drug development for early-stage trials with infrastructure for radiotracer production, a training platform for young researchers, and certified infrastructure for isotope production to aid industry partners in developing new diagnostic and therapeutic substances.

The institute will also secure a local supply of several important medical isotopes, including technetium-99m (Tc-99m), the shortage of which has set off a crisis within the nuclear medicine community, leading to delays in necessary exams for patients. The availability of the radioisotope is expected to further be strained in the first half of November due to the simultaneous shutdowns of Australia’s OPAL reactor and South Africa’s NTP Radioisotopes facility.
  Pages: 1 - 2 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS